Your browser doesn't support javascript.
loading
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.
Isshiki, Masashi; Sakuma, Ichiro; Hayashino, Yasuaki; Sumita, Takashi; Hara, Kazuo; Takahashi, Kazuhisa; Shiojima, Ichiro; Satoh-Asahara, Noriko; Kitazato, Hiroji; Ito, Daisuke; Saito, Daigo; Hatano, Masako; Ikegami, Yuichi; Iida, Shinichiro; Shimada, Akira; Noda, Mitsuhiko.
Afiliação
  • Isshiki M; Department of Endocrinology and Diabetes, Saitama Medical University Hospital, Saitama 350-0495, Japan.
  • Sakuma I; Caress Sapporo Hokko Memorial Clinic, Hokkaido 065-0027, Japan.
  • Hayashino Y; Department of Endocrinology, Tenri Hospital, Nara 632-8552, Japan.
  • Sumita T; Department of Endocrinology and Diabetes, Japanese Red Cross Ogawa Hospital, Saitama 355-0397, Japan.
  • Hara K; Department of Medicine, Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Takahashi K; Department of Medicine II, Kansai Medical University, Osaka 573-1191, Japan.
  • Shiojima I; Department of Medicine II, Kansai Medical University, Osaka 573-1191, Japan.
  • Satoh-Asahara N; Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
  • Kitazato H; Division of Diabetes and Endocrinology, Japanese Red Cross Omori Hospital, Tokyo 143-8527, Japan.
  • Ito D; Department of Endocrinology and Diabetes, Saitama Medical University Hospital, Saitama 350-0495, Japan.
  • Saito D; Department of Endocrinology and Diabetes, Japanese Red Cross Ogawa Hospital, Saitama 355-0397, Japan.
  • Hatano M; Department of Endocrinology and Diabetes, Saitama Medical University Hospital, Saitama 350-0495, Japan.
  • Ikegami Y; Department of Endocrinology and Diabetes, Japanese Red Cross Ogawa Hospital, Saitama 355-0397, Japan.
  • Iida S; Department of Endocrinology and Diabetes, Saitama Medical University Hospital, Saitama 350-0495, Japan.
  • Shimada A; Department of Endocrinology and Diabetes, Saitama Medical University Hospital, Saitama 350-0495, Japan.
  • Noda M; Department of General Internal Medicine, Saitama Medical University Hospital, Saitama 350-0495, Japan.
Endocr J ; 67(11): 1127-1138, 2020 Nov 28.
Article em En | MEDLINE | ID: mdl-32612066
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores da Enzima Conversora de Angiotensina / Renina / Diabetes Mellitus Tipo 2 / Aldosterona / Antagonistas de Receptores de Angiotensina / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Hipertensão Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr J Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores da Enzima Conversora de Angiotensina / Renina / Diabetes Mellitus Tipo 2 / Aldosterona / Antagonistas de Receptores de Angiotensina / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Hipertensão Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Endocr J Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão